SE448730B - Nya 1-(4,4-difenylbutyl)piperazin-karboxamider och karbotioamider samt anvendning av dessa foreningar for framstellning av medel for behandling av vissa sjukdomstillstand - Google Patents

Nya 1-(4,4-difenylbutyl)piperazin-karboxamider och karbotioamider samt anvendning av dessa foreningar for framstellning av medel for behandling av vissa sjukdomstillstand

Info

Publication number
SE448730B
SE448730B SE7908701A SE7908701A SE448730B SE 448730 B SE448730 B SE 448730B SE 7908701 A SE7908701 A SE 7908701A SE 7908701 A SE7908701 A SE 7908701A SE 448730 B SE448730 B SE 448730B
Authority
SE
Sweden
Prior art keywords
carbon atoms
hydrogen
formula
groups
compound
Prior art date
Application number
SE7908701A
Other languages
English (en)
Swedish (sv)
Other versions
SE7908701L (sv
Inventor
A K K Bjork
K G Olsson
A L Abramo
E G Christensson
Original Assignee
Ferrosan Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrosan Ab filed Critical Ferrosan Ab
Publication of SE7908701L publication Critical patent/SE7908701L/
Publication of SE448730B publication Critical patent/SE448730B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/194—Radicals derived from thio- or thiono carboxylic acids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L1/00—Enclosures; Chambers
    • B01L1/52—Transportable laboratories; Field kits

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
SE7908701A 1978-10-20 1979-10-19 Nya 1-(4,4-difenylbutyl)piperazin-karboxamider och karbotioamider samt anvendning av dessa foreningar for framstellning av medel for behandling av vissa sjukdomstillstand SE448730B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7810971 1978-10-20

Publications (2)

Publication Number Publication Date
SE7908701L SE7908701L (sv) 1980-04-21
SE448730B true SE448730B (sv) 1987-03-16

Family

ID=20336152

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7908701A SE448730B (sv) 1978-10-20 1979-10-19 Nya 1-(4,4-difenylbutyl)piperazin-karboxamider och karbotioamider samt anvendning av dessa foreningar for framstellning av medel for behandling av vissa sjukdomstillstand

Country Status (21)

Country Link
US (3) US4308387A (cs)
JP (1) JPS5557572A (cs)
AT (1) AT376666B (cs)
AU (1) AU529260B2 (cs)
BE (1) BE879528A (cs)
CA (1) CA1130807A (cs)
CH (1) CH643247A5 (cs)
DE (1) DE2941880A1 (cs)
DK (1) DK149057C (cs)
ES (1) ES485188A1 (cs)
FI (1) FI73986C (cs)
FR (1) FR2439187A1 (cs)
GB (1) GB2037745B (cs)
HK (1) HK57184A (cs)
IT (1) IT1207269B (cs)
LU (1) LU81807A1 (cs)
NL (2) NL190160C (cs)
NO (1) NO154582C (cs)
NZ (1) NZ191867A (cs)
SE (1) SE448730B (cs)
SG (1) SG7384G (cs)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE791501A (fr) * 1971-11-19 1973-05-17 Albert Ag Chem Werke Diamines cycliques n,n'-disubstituees et leur procede de preparation
EP0061453A1 (en) * 1980-06-16 1982-10-06 AB Ferrosan Diphenylbutyl-1-acylpiperazines
JPS58502056A (ja) * 1981-12-02 1983-12-01 アクチ−ボラグ　フエロサン １−ピペラジノカルボキシレ−ト、それらの製造方法およびそれらを含む医薬組成物
US4543352A (en) * 1983-04-29 1985-09-24 William H. Rorer, Inc. Naphthalene aminoalkylene ethers and thioethers, and their pharmaceutical uses
AT387572B (de) * 1983-05-20 1989-02-10 Ferrosan Ab Verfahren zur herstellung von neuen 4-(4,4-bis-(p-fluorphenyl)-butyl)-1-carbophenox -piperazinen und von 1-piperazincarboxamiden
ES524680A0 (es) * 1983-08-02 1984-12-16 Espanola Farma Therapeut Procedimiento de obtencion de nuevos compuestos derivados de la difenil-metilen-etilamina.
SE8304361D0 (sv) * 1983-08-10 1983-08-10 Ferrosan Ab Novel 1-acylpiperazine derivatives novel 1-acylpiperazine derivatives
FR2558162B1 (fr) * 1984-01-17 1986-04-25 Adir Nouveaux derives de la xanthine, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
SE8500573D0 (sv) * 1985-02-08 1985-02-08 Ferrosan Ab Novel piperazinecarboxamides having a phenoxyalkyl or thiophenoxyalkyl side chain
US4960776A (en) * 1987-01-28 1990-10-02 A. H. Robins Company, Inc. 4-aryl-N-(alkylaminoalkyl, heterocyclicamino and heterocyclicamino)alkyl)-1-piperazinecarboxamides
WO1990013539A1 (en) * 1989-04-28 1990-11-15 Meiji Seika Kaisha, Ltd. New n-substituted piperazine derivatives and drug for improving functional disorder of brain
FR2673182A1 (fr) * 1991-02-22 1992-08-28 Univ Caen Piperazines n,n'-disubstituees, leur procede de preparation et leur application en therapeutique.
SE9100860D0 (sv) * 1991-03-22 1991-03-22 Kabi Pharmacia Ab New use
SE9201239D0 (sv) * 1992-04-21 1992-04-21 Kabi Pharmacia Ab Agents for treating substance abuse disorders
DE4219973A1 (de) * 1992-06-19 1993-12-23 Basf Ag N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
SE9202266D0 (sv) * 1992-07-31 1992-07-31 Kabi Pharmacia Ab Novel piperazine carboxamides
DE4307181C1 (de) * 1993-03-08 1994-11-10 Dresden Arzneimittel Verfahren zur Herstellung von 5H-Dibenz/b,f/azepin-5-carboxamid
DE4341403A1 (de) * 1993-12-04 1995-06-08 Basf Ag N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
JP3274579B2 (ja) * 1995-01-12 2002-04-15 住友製薬株式会社 脳血管障害に伴う精神症候治療剤
DE29815747U1 (de) 1998-09-02 2000-01-05 Ramsauer, Dieter, 42555 Velbert Anschraubscharnier mit Raststellung
USRE39921E1 (en) 1999-10-07 2007-11-13 Smithkline Beecham Corporation Chemical compounds
GB9923748D0 (en) * 1999-10-07 1999-12-08 Glaxo Group Ltd Chemical compounds
GB0025354D0 (en) * 2000-10-17 2000-11-29 Glaxo Group Ltd Chemical compounds
GB0108594D0 (en) * 2001-04-05 2001-05-23 Glaxo Group Ltd Chemical compounds
US7141250B2 (en) * 2001-08-06 2006-11-28 Euro-Celtique S.A. Pharmaceutical formulation containing bittering agent
US7842307B2 (en) 2001-08-06 2010-11-30 Purdue Pharma L.P. Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent
US7332182B2 (en) 2001-08-06 2008-02-19 Purdue Pharma L.P. Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant
US20030044458A1 (en) 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
US7157103B2 (en) 2001-08-06 2007-01-02 Euro-Celtique S.A. Pharmaceutical formulation containing irritant
GB0203022D0 (en) * 2002-02-08 2002-03-27 Glaxo Group Ltd Chemical compounds
WO2003066589A1 (en) * 2002-02-08 2003-08-14 Glaxo Group Limited Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
GB0203020D0 (en) * 2002-02-08 2002-03-27 Glaxo Group Ltd Chemical compounds
CA2569958C (en) 2004-06-12 2016-03-22 Jane C. Hirsh Abuse-deterrent drug formulations
JP4823673B2 (ja) * 2005-12-15 2011-11-24 タカラベルモント株式会社 ショックレス弁を接続した油圧回路
JP2010169206A (ja) * 2009-01-23 2010-08-05 Finesinter Co Ltd ノンリークショックレス電磁比例制御弁
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
KR101647267B1 (ko) 2010-12-22 2016-08-09 퍼듀 퍼머 엘피 케이싱된 탬퍼 저항성 제어 방출 투여 형태
PH12013501345A1 (en) 2010-12-23 2022-10-24 Purdue Pharma Lp Tamper resistant solid oral dosage forms
EA201500742A1 (ru) 2013-02-05 2015-12-30 Пердью Фарма Л.П. Защищенные от нецелевого использования фармацевтические композиции
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
WO2017222575A1 (en) 2016-06-23 2017-12-28 Collegium Pharmaceutical, Inc. Process of making more stable abuse-deterrent oral formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL137318C (cs) * 1964-06-09
JPS518283A (en) * 1974-07-09 1976-01-23 Kyorin Seiyaku Kk 11 * 33 fuenirupuropiru * 44 karubamoirupiperajinjudotaino seizoho
JPS5346988A (en) * 1976-10-07 1978-04-27 Kyorin Seiyaku Kk Piperadine derivative

Also Published As

Publication number Publication date
NL940004I1 (nl) 1994-05-02
FR2439187B1 (cs) 1983-03-18
NO793315L (no) 1980-04-22
US4385057A (en) 1983-05-24
FI73986C (fi) 1987-12-10
HK57184A (en) 1984-08-03
JPS5557572A (en) 1980-04-28
NL190160B (nl) 1993-06-16
CA1130807A (en) 1982-08-31
NZ191867A (en) 1983-06-14
NL7907741A (nl) 1980-04-22
US4447433A (en) 1984-05-08
LU81807A1 (de) 1980-01-25
CH643247A5 (de) 1984-05-30
DE2941880A1 (de) 1980-04-30
NL190160C (nl) 1993-11-16
US4308387A (en) 1981-12-29
AT376666B (de) 1984-12-27
JPS6326756B2 (cs) 1988-05-31
NO154582B (no) 1986-07-28
AU5198479A (en) 1980-06-19
DK149057C (da) 1986-06-02
GB2037745B (en) 1982-11-24
BE879528A (fr) 1980-04-21
FI73986B (fi) 1987-08-31
DK149057B (da) 1986-01-06
NO154582C (no) 1986-11-05
DE2941880C2 (cs) 1989-04-20
FI793238A7 (fi) 1980-04-21
SG7384G (en) 1985-02-08
IT7926603A0 (it) 1979-10-18
DK442779A (da) 1980-04-21
AU529260B2 (en) 1983-06-02
SE7908701L (sv) 1980-04-21
ATA683479A (de) 1984-05-15
FR2439187A1 (fr) 1980-05-16
ES485188A1 (es) 1980-05-16
IT1207269B (it) 1989-05-17
GB2037745A (en) 1980-07-16

Similar Documents

Publication Publication Date Title
SE448730B (sv) Nya 1-(4,4-difenylbutyl)piperazin-karboxamider och karbotioamider samt anvendning av dessa foreningar for framstellning av medel for behandling av vissa sjukdomstillstand
DE69219394T2 (de) Heterozyklische Alkylamide, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
RU2118320C1 (ru) Энантиомеры 1-[(4-хлорфенил)фенилметил]-4-[(4-метилфенил)сульфонил]пиперазина, способ их получения, способ получения энантиомеров 1-[(4-хлорфенил)фенилметил]пиперазина, энантиомеры 1-[(4-хлорфенил)фенилметил]пиперазина,энантиомеры производных 1-[(4-хлорфенил)фенилметил]пиперазина
US4252804A (en) Therapeutically useful 3,4,5-trimethoxybenzene derivatives
AU569537B2 (en) Novel 1-piperazinecarboxamide derivatives
PL144921B1 (en) Method of obtaining novel susbtituted pyrolidinone
EP0211928B1 (en) Piperazinecarboxamides having a phenoxyalkyl or thiophenoxyalkyl side chain
US4358456A (en) Antipsychotic piperidinomethyl-indole derivatives
US3459757A (en) Imidazolidines
DE2811031A1 (de) Piperazin-3-indole, verfahren zu ihrer herstellung und ihre therapeutische verwendung
JPH0819064B2 (ja) インダンの新誘導体、それらの製造法及び薬剤としての使用
US3474090A (en) 3-aminoalkyl-1,3-benzodiazepin-2-ones
CH643263A5 (de) Benzodiazepine, ihre herstellung und verwendung.
DE69230498T2 (de) 2-Pyrazinylethylamin-Derivate und ihre Verwendung als Arzneimittel.
DE2900288A1 (de) Aminoderivate von pyrazol eckige klammer auf 1,5-a eckige klammer zu s-triazin, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE69126537T2 (de) (2-thienyl)alkylaminderivate mit nervenschützenden eigenschaften
JPS63264445A (ja) 新規のインダン誘導体、その製造方法及び薬剤としてのその使用
CA1094070A (en) 1-phenyl-piperazine derivatives
EP0089089A1 (en) Phenyl piperazine derivatives having antiaggressive activity
EP0080992B1 (en) 1-piperazinocarboxylates, process for their preparation and pharmaceutical compositions containing them
DE2456947A1 (de) Neue alkensulfonamide, deren herstellung und diese enthaltende arzneimittel
Harfenist Quaternary Piperazines with Anti-pinworm Activity1
US3900563A (en) Method of using 3-(2-(4-phenyl-1-piperazinyl)ethyl)-indolines
DE69431441T2 (de) Trizyklische verbindungen mit affinität für den 5-ht1a rezeptor
US4183933A (en) Diarylbutyl octahydropyrazinopyrimidinones and methods of medical treatment using them

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7908701-1

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7908701-1

Format of ref document f/p: F